Register
Register
Register

Project cooperationUpdated on 23 February 2026

PancreaTwin: Multi‑Fluid Digital Twin for Pancreatic Cancer Research

representador legal at TORMENTA‑IA3, SL

Madrid, Spain

About

PancreaTwin is a multi‑fluid digital twin platform designed for advanced research in pancreatic cancer. It integrates biomarkers from blood, saliva and urine to generate a dynamic representation of the biological state, enabling the visualization of metabolic, inflammatory and molecular patterns associated with disease progression. The system supports longitudinal studies, trend analysis and scenario simulation within a research context.

PancreaTwin operates both in local mode and through extendable API modules, allowing use in environments with limited connectivity. The platform is ready for integration into Horizon Europe consortia focused on digital twins, AI for health research, biomarker‑driven studies, research infrastructures and clinical innovation Living Labs.

Stage

  • Design - setting the project scope
  • Completing the consortia

Topic

  • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
  • HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
  • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
  • HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
  • HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
  • HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
  • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients

Type

  • Consortium/Coordinator seeks Partners
  • Offering Expertise to Consortias

Organisation

TORMENTA‑IA3, SL

Company (SME)

Madrid, Spain

Similar opportunities

  • Project cooperation

    Facilitating contacts with cancer researchers at Medical University of Vienna

    • Completing the consortia
    • HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
    • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
    • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
    • HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
    • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers

    Reinhard Eckert

    Research Service at Medical University of Vienna

    Vienna, Austria

  • Project cooperation

    OncoTwin 2030: AI‑Driven Digital Twin Platform for Oncology Decision Support

    • Completing the consortia
    • Offering Expertise to Consortias
    • Design - setting the project scope
    • HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
    • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
    • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
    • HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
    • HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
    • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
    • HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)

    Dani Ortiz

    representador legal at TORMENTA‑IA3, SL

    Madrid, Spain

  • Project cooperation

    SME biotech partner offering integrated genomic and epigenomic profiling for early cancer prediction

    • Offering Expertise to Consortias
    • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
    • HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
    • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers

    Ana Pou

    Project Manager at Aniling

    Barcelona, Spain